- Home
- VRAR vs POCI Comparison
VRAR vs POCI Comparison
Compare VRAR & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAR
- POCI
- Stock Information
- Founded
- VRAR 2016
- POCI 1982
- Country
- VRAR United States
- POCI United States
- Employees
- VRAR N/A
- POCI N/A
- Industry
- VRAR Retail: Computer Software & Peripheral Equipment
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VRAR Technology
- POCI Health Care
- Exchange
- VRAR Nasdaq
- POCI Nasdaq
- Market Cap
- VRAR 33.3M
- POCI 35.1M
- IPO Year
- VRAR 2021
- POCI N/A
- Fundamental
- Price
- VRAR $1.49
- POCI $4.96
- Analyst Decision
- VRAR Strong Buy
- POCI
- Analyst Count
- VRAR 1
- POCI 0
- Target Price
- VRAR $2.62
- POCI N/A
- AVG Volume (30 Days)
- VRAR 135.2K
- POCI 16.1K
- Earning Date
- VRAR 05-15-2025
- POCI 05-15-2025
- Dividend Yield
- VRAR N/A
- POCI N/A
- EPS Growth
- VRAR N/A
- POCI N/A
- EPS
- VRAR N/A
- POCI N/A
- Revenue
- VRAR $8,756,789.00
- POCI $17,626,155.00
- Revenue This Year
- VRAR $23.96
- POCI N/A
- Revenue Next Year
- VRAR $12.15
- POCI N/A
- P/E Ratio
- VRAR N/A
- POCI N/A
- Revenue Growth
- VRAR N/A
- POCI N/A
- 52 Week Low
- VRAR $0.50
- POCI $3.47
- 52 Week High
- VRAR $7.00
- POCI $6.59
- Technical
- Relative Strength Index (RSI)
- VRAR 52.95
- POCI 62.07
- Support Level
- VRAR $1.31
- POCI $4.62
- Resistance Level
- VRAR $1.38
- POCI $5.10
- Average True Range (ATR)
- VRAR 0.11
- POCI 0.32
- MACD
- VRAR 0.01
- POCI 0.02
- Stochastic Oscillator
- VRAR 66.67
- POCI 90.48
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.